Definition:
Connected Biosensors are devices that collect information on a variety of health parameters and vital signs of an individual, such as blood pressure, temperature, and blood glucose, by reading or measuring this data and transmitting it via electrical signals. This market also includes social alarms as an example of ambient assisted living technologies, which are emerging technologies enabled by IoT, AI, sensors, and wireless communication technologies with the goal of helping elderly people live safely and independently in their environment.Structure:
The Connected Biosensors market is divided into four categories: thermometers, blood glucose meters, blood pressure meters, and social alarms.Additional Information:
The market data comprises revenue, average revenue per user, users, and user penetration rates. The data only reflects B2C revenues; B2B and C2C revenues are not covered.Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Jul 2024
Most recent update: Jun 2024
Source: Statista Market Insights
The Connected Biosensors market in United States is experiencing a significant growth trajectory driven by various factors influencing consumer preferences, technological advancements, and local special circumstances.
Customer preferences: Consumers in the United States are increasingly gravitating towards connected biosensors due to the convenience and real-time health monitoring capabilities they offer. The demand for smart thermometers, smart blood glucose meters, smart blood pressure meters, and social alarms is rising as individuals seek more personalized and proactive healthcare solutions. Additionally, the growing awareness about the importance of health and wellness is prompting consumers to invest in connected biosensors to track their vital signs and health metrics more effectively.
Trends in the market: One of the prominent trends in the Connected Biosensors market in the United States is the integration of advanced technologies such as Internet of Things (IoT), artificial intelligence, and machine learning. These technologies enhance the functionality of biosensors by enabling seamless data collection, analysis, and interpretation. Moreover, the market is witnessing a surge in the development of wearable biosensors that offer continuous monitoring and greater mobility to users. This trend is reshaping the healthcare landscape by providing healthcare professionals with valuable insights for early diagnosis and intervention.
Local special circumstances: The United States has a robust healthcare infrastructure and a culture that emphasizes innovation and technology adoption. This environment fosters the rapid growth of the Connected Biosensors market as healthcare providers, insurance companies, and consumers embrace digital health solutions. Furthermore, the presence of leading technology companies and research institutions in the country accelerates the pace of innovation in biosensor technology. The regulatory environment in the United States also plays a crucial role in shaping the market dynamics by ensuring the safety, efficacy, and interoperability of connected biosensors.
Underlying macroeconomic factors: The growing healthcare expenditure, increasing prevalence of chronic diseases, and aging population in the United States are key macroeconomic factors driving the demand for connected biosensors. As healthcare costs continue to rise, there is a growing emphasis on preventive care and remote monitoring solutions, making connected biosensors a viable option for both healthcare providers and patients. Additionally, the shift towards value-based care and outcomes-based reimbursement models incentivizes the adoption of digital health technologies like connected biosensors to improve patient outcomes and reduce healthcare costs in the long run.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.Modeling approach / Market size:
Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.Additional notes:
The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights